186 related articles for article (PubMed ID: 20075714)
1. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.
Zhao H; Yang G; Wang D; Yu X; Zhang Y; Zhu J; Ji Y; Zhong B; Zhao W; Yang Z; Aziz F
Anticancer Drugs; 2010 Apr; 21(4):447-52. PubMed ID: 20075714
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of survival factors of high intensity focused ultrasound (HIFU) treatment for unresectable pancreatic cancer.
Ning ZY; Cheng CS; Xie J; Chen QW; Xu LT; Zhuang LP; Zhang CY; Song LB; Shi WD; Zhu XY; Wang P; Wang K; Meng ZQ
Discov Med; 2016 Jun; 21(118):435-45. PubMed ID: 27448780
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy evaluation of high intensity focused ultrasound combined with intra-arterial infusion of gemcitabine in the treatment of pancreatic cancer].
Zhong GC; Zhang XY; Chen J; Sun Y; Zhang WH; Gui YZ; Long HX; Zhu B
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):68-72. PubMed ID: 22490861
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
Wolff RA; Evans DB; Gravel DM; Lenzi R; Pisters PW; Lee JE; Janjan NA; Charnsangavej C; Abbruzzese JL
Clin Cancer Res; 2001 Aug; 7(8):2246-53. PubMed ID: 11489798
[TBL] [Abstract][Full Text] [Related]
5. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
Brade A; Brierley J; Oza A; Gallinger S; Cummings B; Maclean M; Pond GR; Hedley D; Wong S; Townsley C; Brezden-Masley C; Moore M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1027-36. PubMed ID: 17197132
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
Alberts SR; Schroeder M; Erlichman C; Steen PD; Foster NR; Moore DF; Rowland KM; Nair S; Tschetter LK; Fitch TR
J Clin Oncol; 2004 Dec; 22(24):4944-50. PubMed ID: 15611509
[TBL] [Abstract][Full Text] [Related]
7. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.
Blackstock AW; Tepper JE; Niedwiecki D; Hollis DR; Mayer RJ; Tempero MA
Int J Gastrointest Cancer; 2003; 34(2-3):107-16. PubMed ID: 15361643
[TBL] [Abstract][Full Text] [Related]
8. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.
Pipas JM; Zaki BI; McGowan MM; Tsapakos MJ; Ripple GH; Suriawinata AA; Tsongalis GJ; Colacchio TA; Gordon SR; Sutton JE; Srivastava A; Smith KD; Gardner TB; Korc M; Davis TH; Preis M; Tarczewski SM; MacKenzie TA; Barth RJ
Ann Oncol; 2012 Nov; 23(11):2820-2827. PubMed ID: 22571859
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer.
Ishikawa T; Kokura S; Sakamoto N; Ando T; Imamoto E; Hattori T; Oyamada H; Yoshinami N; Sakamoto M; Kitagawa K; Okumura Y; Yoshida N; Kamada K; Katada K; Uchiyama K; Handa O; Takagi T; Yasuda H; Sakagami J; Konishi H; Yagi N; Naito Y; Yoshikawa T
Int J Hyperthermia; 2012; 28(7):597-604. PubMed ID: 22838644
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.
Ishii H; Furuse J; Boku N; Okusaka T; Ikeda M; Ohkawa S; Fukutomi A; Hamamoto Y; Nakamura K; Fukuda H;
Jpn J Clin Oncol; 2010 Jun; 40(6):573-9. PubMed ID: 20185458
[TBL] [Abstract][Full Text] [Related]
12. Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.
Cengiz M; Zorlu F; Yalcin S; Gurkaynak M; Atahan IL; Gullu IH
Med Oncol; 2007; 24(2):239-43. PubMed ID: 17848750
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study.
Cardenes HR; Moore AM; Johnson CS; Yu M; Helft P; Chiorean EG; Vinson J; Howard TJ; Stephens AW; Tai DF; Loehrer PJ
Am J Clin Oncol; 2011 Oct; 34(5):460-5. PubMed ID: 20881474
[TBL] [Abstract][Full Text] [Related]
14. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
Philip PA; Lacy J; Portales F; Sobrero A; Pazo-Cid R; Manzano Mozo JL; Kim EJ; Dowden S; Zakari A; Borg C; Terrebonne E; Rivera F; Sastre J; Bathini V; López-Trabada D; Asselah J; Saif MW; Shiansong Li J; Ong TJ; Nydam T; Hammel P
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):285-294. PubMed ID: 31953079
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.
Ammori JB; Colletti LM; Zalupski MM; Eckhauser FE; Greenson JK; Dimick J; Lawrence TS; McGinn CJ
J Gastrointest Surg; 2003; 7(6):766-72. PubMed ID: 13129554
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences.
Lee JY; Choi BI; Ryu JK; Kim YT; Hwang JH; Kim SH; Han JK
Korean J Radiol; 2011; 12(2):176-86. PubMed ID: 21430934
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.
Blackstock AW; Bernard SA; Richards F; Eagle KS; Case LD; Poole ME; Savage PD; Tepper JE
J Clin Oncol; 1999 Jul; 17(7):2208-12. PubMed ID: 10561277
[TBL] [Abstract][Full Text] [Related]
18. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
Small W; Berlin J; Freedman GM; Lawrence T; Talamonti MS; Mulcahy MF; Chakravarthy AB; Konski AA; Zalupski MM; Philip PA; Kinsella TJ; Merchant NB; Hoffman JP; Benson AB; Nicol S; Xu RM; Gill JF; McGinn CJ
J Clin Oncol; 2008 Feb; 26(6):942-7. PubMed ID: 18281668
[TBL] [Abstract][Full Text] [Related]
19. Pulsed high-intensity focused ultrasound enhances apoptosis of pancreatic cancer xenograft with gemcitabine.
Lee ES; Lee JY; Kim H; Choi Y; Park J; Han JK; Choi BI
Ultrasound Med Biol; 2013 Nov; 39(11):1991-2000. PubMed ID: 23972483
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
Sudo K; Yamaguchi T; Ishihara T; Nakamura K; Hara T; Denda T; Tawada K; Imagumbai T; Araki H; Sakai M; Hatano K; Kawakami H; Uno T; Ito H; Yokosuka O
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):119-25. PubMed ID: 20605363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]